ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial group.
When a person receives a diagnosis of amyotrophic lateral sclerosis (ALS), a doctor may prescribe one or more different medications to help treat symptoms and slow the disease’s progression. At ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback